← Back
$BPMC All transactions

Blueprint Medicines Corp

▼ SELL 10b5-1 Plan

$ Value

$66K

Shares

650

Price

$102

Filed

May 29

Insider

Name

Albers Jeffrey W.

Title

CIK

0001638474

Roles

Director

Transaction Details

Transaction Date

2025-05-27

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

146,630

Footnotes

Effected pursuant to a trading plan adopted on May 8, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $100.42 to $101.34 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $101.53 to $102.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | This option was granted on February 16, 2017 and is fully vested as of the transaction date.

Filing Info

Accession No.

0001415889-25-014862

Form Type

4

Issuer CIK

0001597264

Albers Jeffrey W.'s History

Date Ticker Type Value
2025-12-08 KYMR M $71K
2025-12-08 KYMR $245K
2025-12-08 KYMR $203K
2025-12-08 KYMR M $0
2025-10-13 KYMR M $52K
2025-10-13 KYMR $296K
2025-10-13 KYMR M $0
2025-07-17 BPMC D
2025-07-17 BPMC U
2025-07-17 BPMC D

Other Insiders at BPMC (90d)

No other insider activity at this issuer in the last 90 days.